Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Feb 1;145(2):293-301.
doi: 10.1084/jem.145.2.293.

Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes

Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes

B Bonavida. J Exp Med. .

Abstract

A secondary specific cytotoxic response is obtained when lymphocytes primed in vivo to a tumor allograft are exposed to Con A in culture. The secondary cytotoxic cells generated are specific to target cells bearing antigens of the primary sensitizing cells and are qualitatively indistinguishable from the response obtained upon secondary antigenic stimulation. The cell-mediated cytotoxicity is independent of concanavalin A (Con A) and is not affected by the Con A-specific inhibitor, alpha-methyl-D-mannose pyranoside. Furthermore, cultures containing a mixture of submitogenic concentrations of Con A and stimulating antigens showed synergy and augmentation of cytotoxic activity. It is suggested that activation of prekiller cells by Con A into CTL may be mediated via the same or similar receptors normally triggered by the stimulating antigens. Functional similarities between ConA and the lymphocyte-defined antigens of the major histocompatibility complex region are discussed.

PubMed Disclaimer

References

    1. J Exp Med. 1974 Sep 1;140(3):703-17 - PubMed
    1. J Exp Med. 1974 Sep 1;140(3):718-30 - PubMed
    1. J Immunol. 1974 Mar;112(3):926-34 - PubMed
    1. J Exp Med. 1973 Dec 1;138(6):1379-97 - PubMed
    1. Eur J Immunol. 1972 Dec;2(6):586-92 - PubMed

Publication types

MeSH terms